글로벌 유잉 육종 약물 시장: 광범위한 연구 개발을 통해 시장 참여자에게 기회적 성장을 창출합니다.

글로벌 유잉 육종 약물 시장

유잉 육종 치료제는 환자의 뼈, 연조직, 그리고 뼈 주변 신경에 널리 발생하는 희귀 암종인 유잉 육종 치료를 위해 개발된 의약품입니다. 이 질환은 매우 드물기 때문에 효과적인 치료법이 매우 제한적이며, 따라서 대부분의 제약사들은 환자의 암 유병률을 줄일 수 있는 효과적인 의약품 개발에 집중하고 있습니다.

https://www.databridgemarketresearch.com/reports/global-ewing-sarcoma-drug-market 에서 전체 보고서를 확인하세요.

유잉 육종 약물 시장은 전 세계적으로 유잉 육종 발병률이 증가하고, 정부 기관에서 유잉 육종으로 인한 이환율을 줄이기 위한 조치를 취함에 따라 성장하고 있습니다. 이러한 요소의 영향은 아래와 같습니다.

전 세계적으로 유잉 육종 발생률 증가: 이 유형의 암은 유병률이 낮지만, 골종양 발생률이 유잉 육종 유병률에 상당한 영향을 미치면서 전 세계적으로 유잉 육종 유병률이 증가하고 있습니다. 이러한 유병률 증가로 인해 다양한 치료법과 치료법에 대한 수요가 증가하고 있습니다.

유잉 육종 발병률 감소를 위한 정부 기관의 노력: 유잉 육종 발병률 증가에 따라 여러 지역 정부는 다양한 프로그램을 시작하고, 개인 및 제약 회사들을 대상으로 효과적인 유잉 육종 치료제 개발에 대한 인식을 제고했습니다. 이러한 노력은 유잉 육종 관련 발병률 감소에 집중되어 왔으며, 이는 해당 지역의 의료비 지출에 상당한 영향을 미칩니다.

혁신적 약물의 승인 및 해당 약물에 대한 임상 시험의 종료:

2019년 8월, 셀렉타 바이오사이언스(Cellectar Biosciences, Inc.)는 현재 진행 중인 소아 및 청소년 대상 CLR 131의 1상 임상시험을 위한 악성 뇌종양 환자 1차 코호트 모집을 완료했다고 발표했습니다. 해당 후보물질은 연구 진행 속도가 매우 빠르며, 셀렉타 바이오사이언스는 현재 후보물질의 효능에 대한 추가 정보를 수집하기 위해 다음 단계와 용량을 모색하고 있습니다.

2018년 8월, Gradalis, Inc.는 유잉 육종 환자 치료를 위한 "Vigil"의 3상 임상 시험을 시작했다고 발표했습니다. Gradalis는 자사의 암 치료용 면역치료 플랫폼을 활용하여 이 약물의 다른 개별 목표 달성을 모색할 것입니다.

시장은 뼈 종양, 연부 조직(골외) 종양, pPNET, 피부 종양 등의 유형을 기준으로 세분화됩니다. 진단은 신체 검사, 혈액 검사, PET 스캔, X선, 뼈 스캔, MRI, CAT/CT 스캔, 골수 흡인, 생검으로 분류됩니다. 치료는 화학 요법, 방사선 요법, 수술로 이루어집니다. 작용 기전은 TKI, 단일 클론 항체, 체크포인트 억제제, 백신으로 이루어집니다. 약물 유형으로는 빈크리스틴, 사이클로포스파마이드, 독소루비신, 에토포사이드, 이포스파마이드, 닥티노마이신이 있습니다. 투여 경로로는 경구, 정맥 주사, 기타가 있으며, 최종 사용자는 병원, 재택 치료, 전문 클리닉, 기타입니다.

Data Bridge Market Research에 따르면, 글로벌 유잉 육종 약물 시장은 2019년부터 2026년까지의 예측 기간 동안 꾸준한 CAGR로 성장할 것으로 예상됩니다.

시장에서 활동하는 주요 기업으로는 Merck & Co., Inc, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, Pfizer Inc, Johnson & Johnson Services, Inc, Abbott, Sanofi, Bausch Health, Eli Lilly and Company, AbbVie Inc, Takeda Pharmaceutical Company Limited, Amgen Inc, AstraZeneca, Bristol-Myers Squibb Company, Bayer AG, DAIICHI SANKYO COMPANY, LIMITED, CELGENE CORPORATION, Eisai Co., Ltd, Gradalis, Inc, Incyte Corporation 등이 있습니다.

유잉 육종 유병률 증가와 더불어 관련 질병 이환율 감소에 대한 당국의 압력이 커짐에 따라, 대부분의 제조업체는 관계 당국의 승인을 받고 시판될 수 있는 효과적인 치료 시스템 개발을 위한 연구 개발 활동을 강화하고 있습니다.

CHOOSE LICENCE TYPE

Enterprise User 7000
Single User 4800
DBMR Factbook 3000
DBMR Prime 8000
DBMR Nucleus 12000

Buy Now

Advance Formative Research Customization Request for bulk Reports

Latest News

Global Oral Insulin Market for Type 1 and Type 2 Diabetes:

Top Key Players in the Agriculture Variable Rate Technology Market: Enhancing Precision Farming for Higher Efficiency

Leading Players in the AI in Agriculture Market: Revolutionizing Farming with Smart Technologies

Leading Players in the Farm Management Software Market: Driving Digital Transformation in Agriculture

Leading Players in the Data Center Service Market: Enhancing Digital Infrastructure with Scalable and Secure Solutions

VIEW ALL

Client Testimonials

Claudio Rondena

Group Business Development & Strategic Marketing Director,
C.O.C Farmaceutici SRL

"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."

David Manning - Thermo Fisher Scientific

Director, Global Strategic Accounts,

Dear Ricky,
I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.

Manager - Market Analytics,

Uriah D. Avila - Zeus Polymer Solutions

Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.

Business Development Manager,

(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.

Business Intelligence and Analytics,

Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Competition Analyst,

Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Marketing Director,

Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO,

A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Marketing Director,

Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Product manager,

Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Investor relations,

GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Market Analyst,

Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Andrew - Senior Global Marketing Manager,

Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Amarildo - Manager, Global Strategic Alignment

MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Tor Hammer

Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro

Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department)

UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future